181 related articles for article (PubMed ID: 19773756)
1. Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival.
Dawson SJ; Duffy SW; Blows FM; Driver KE; Provenzano E; LeQuesne J; Greenberg DC; Pharoah P; Caldas C; Wishart GC
Br J Cancer; 2009 Oct; 101(8):1338-44. PubMed ID: 19773756
[TBL] [Abstract][Full Text] [Related]
2. Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone?
Wishart GC; Greenberg DC; Britton PD; Chou P; Brown CH; Purushotham AD; Duffy SW
Br J Cancer; 2008 Jun; 98(11):1741-4. PubMed ID: 18506175
[TBL] [Abstract][Full Text] [Related]
3. Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series.
Crispo A; Barba M; D'Aiuto G; De Laurentiis M; Grimaldi M; Rinaldo M; Caolo G; D'Aiuto M; Capasso I; Esposito E; Amore A; Di Bonito M; Botti G; Montella M
BMC Cancer; 2013 Jan; 13():15. PubMed ID: 23305429
[TBL] [Abstract][Full Text] [Related]
4. Comparison between screen-detected and symptomatic breast cancers according to molecular subtypes.
Kim J; Lee S; Bae S; Choi MY; Lee J; Jung SP; Kim S; Choe JH; Kim JH; Kim JS; Lee JE; Nam SJ; Yang JH
Breast Cancer Res Treat; 2012 Jan; 131(2):527-40. PubMed ID: 22042364
[TBL] [Abstract][Full Text] [Related]
5. Differences in subtype distribution between screen-detected and symptomatic invasive breast cancer and their impact on survival.
Kobayashi N; Hikichi M; Ushimado K; Sugioka A; Kiriyama Y; Kuroda M; Utsumi T
Clin Transl Oncol; 2017 Oct; 19(10):1232-1240. PubMed ID: 28409323
[TBL] [Abstract][Full Text] [Related]
6. Are symptomatic guidelines for chemotherapy appropriate to ER-positive screen-detected breast cancer (SDBC)?
Bundred NJ; Prasad R; Morris J; Knox WF; Byrne G; Cheung S; Wilson M; Lawrence G
Breast Cancer Res Treat; 2013 Apr; 138(2):359-68. PubMed ID: 21744241
[TBL] [Abstract][Full Text] [Related]
7. Mode of detection: an independent prognostic factor for women with breast cancer.
Hofvind S; Holen Å; Román M; Sebuødegård S; Puig-Vives M; Akslen L
J Med Screen; 2016 Jun; 23(2):89-97. PubMed ID: 26582492
[TBL] [Abstract][Full Text] [Related]
8. Is the presence of mammographic comedo calcification really a prognostic factor for small screen-detected invasive breast cancers?
James JJ; Evans AJ; Pinder SE; Macmillan RD; Wilson AR; Ellis IO
Clin Radiol; 2003 Jan; 58(1):54-62. PubMed ID: 12565206
[TBL] [Abstract][Full Text] [Related]
9. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
11. Explaining the difference in prognosis between screen-detected and symptomatic breast cancers.
Allgood PC; Duffy SW; Kearins O; O'Sullivan E; Tappenden N; Wallis MG; Lawrence G
Br J Cancer; 2011 May; 104(11):1680-5. PubMed ID: 21540862
[TBL] [Abstract][Full Text] [Related]
12. The prognosis of small primary breast cancers.
Kollias J; Murphy CA; Elston CW; Ellis IO; Robertson JF; Blamey RW
Eur J Cancer; 1999 Jun; 35(6):908-12. PubMed ID: 10533470
[TBL] [Abstract][Full Text] [Related]
13. St Gallen molecular subtypes in screening-detected and symptomatic breast cancer in a prospective cohort with long-term follow-up.
Falck AK; Röme A; Fernö M; Olsson H; Chebil G; Bendahl PO; Rydén L
Br J Surg; 2016 Apr; 103(5):513-23. PubMed ID: 26856820
[TBL] [Abstract][Full Text] [Related]
14. Tumor characteristics in screen-detected and symptomatic breast cancers.
Pálka I; Kelemen G; Ormándi K; Lázár G; Nyári T; Thurzó L; Kahán Z
Pathol Oncol Res; 2008 Jun; 14(2):161-7. PubMed ID: 18347932
[TBL] [Abstract][Full Text] [Related]
15. Independent prognostic value of screen detection in invasive breast cancer.
Mook S; Van 't Veer LJ; Rutgers EJ; Ravdin PM; van de Velde AO; van Leeuwen FE; Visser O; Schmidt MK
J Natl Cancer Inst; 2011 Apr; 103(7):585-97. PubMed ID: 21350218
[TBL] [Abstract][Full Text] [Related]
16. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
[TBL] [Abstract][Full Text] [Related]
17. Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.
Chuang SL; Chen SL; Yu CP; Chang KJ; Yen AM; Chiu SY; Fann JC; Tabár L; Stephen DW; Smith RA; Chen HH
APMIS; 2014 Aug; 122(8):699-707. PubMed ID: 25046200
[TBL] [Abstract][Full Text] [Related]
18. Tumour characteristics and survival in patients with invasive interval breast cancer classified according to mammographic findings at the latest screening: a comparison of true interval and missed interval cancers.
Vitak B; Olsen KE; Månson JC; Arnesson LG; Stål O
Eur Radiol; 1999; 9(3):460-9. PubMed ID: 10087117
[TBL] [Abstract][Full Text] [Related]
19. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
20. Tumour-related factors and prognosis in breast cancer detected by screening.
Olsson A; Borgquist S; Butt S; Zackrisson S; Landberg G; Manjer J
Br J Surg; 2012 Jan; 99(1):78-87. PubMed ID: 22068957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]